Occam Places CBO for Oncology Biotech Accent Therapeutics
In September 2018, Occam recruited David Brower as Chief Business Officer of Accent Therapeutics, a developer of biomarker-driven cancer medicines.
David has held a number of life science business development, strategy, and investing roles prior to joining Accent. Most recently, he led the business development function for Blueprint Medicines, where he completed various strategic transactions, including its seminal partnerships with Roche Pharmaceuticals, CStone Pharmaceuticals, and Alexion Pharmaceuticals. Prior to Blueprint Medicines, David was a member of Pfizer Pharmaceuticals’ Worldwide Business Development team, focusing on licensing and M&A transactions and business development strategy. David began his career as a healthcare trader and investor for Lehman Brothers and Barclays Capital.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.